Hevin Regulation of Cell Migration

Hevin 对细胞迁移的调节

基本信息

项目摘要

DESCRIPTION (provided by applicant): Extracellular matrix (ECM) structure is a known determinant of cell behavior and is in turn regulated by signals from its adjacent cells. Matricellular proteins such as hevin play an important role in regulating cell/ECM communication and ECM structure by acting as adapters, and therefore are critical regulators of numerous pathologies such as tumor growth and its associated angiogenesis. The hypothesis of this proposal is that hevin functions as a regulator of cell migration by inducing a state of adhesion permissive for migration. The specific aims geared to address this hypothesis are focused on elucidating one or more of the mechanisms through which hevin functions. First, we will investigate the role of the hevin/collagen I interaction in deadhesion, and second, we will examine the mechanism of hevin-induced focal adhesion disassembly. To address the first specific aim, we will evaluate hevin/collagen I binding and its effect on collagen fibril synthesis, structure, and interaction with alpha2beta1-integrin in dermal fibroblasts. To address the second specific aim, we will investigate the signaling pathways involved in regulating focal adhesion disassembly and cell migration by hevin in bovine aortic endothelial cells and dermal fibroblasts.
描述(由申请人提供):细胞外基质(ECM)结构是细胞行为的已知决定因素,进而受来自其相邻细胞的信号调节。基质细胞蛋白如hevin通过充当适配器在调节细胞/ECM通信和ECM结构中起重要作用,因此是许多病理如肿瘤生长及其相关血管生成的关键调节剂。这个提议的假设是hevin通过诱导允许迁移的粘附状态来作为细胞迁移的调节剂。解决这一假说的具体目标集中在阐明一个或多个赫文功能的机制。首先,我们将研究hevin/胶原I相互作用在脱粘中的作用,其次,我们将研究hevin诱导的粘着斑解体的机制。为了解决第一个具体的目标,我们将评估hevin/胶原蛋白I结合及其对胶原纤维的合成,结构和相互作用与α 2 β 1-整联蛋白在真皮成纤维细胞。为了解决第二个具体的目标,我们将调查参与调节局灶性粘附拆卸和细胞迁移的hevin在牛主动脉内皮细胞和真皮成纤维细胞的信号通路。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Millicent O Sullivan其他文献

Engineering protein nanoparticles for drug delivery
工程化蛋白质纳米颗粒用于药物递送
  • DOI:
    10.1016/j.copbio.2024.103070
  • 发表时间:
    2024-04-01
  • 期刊:
  • 影响因子:
    7.000
  • 作者:
    Blake A Richards;Antonio G Goncalves;Millicent O Sullivan;Wilfred Chen
  • 通讯作者:
    Wilfred Chen

Millicent O Sullivan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Millicent O Sullivan', 18)}}的其他基金

Suppressing Radiotherapy-Induced Metastasis in Aggressive Breast Cancers via 'On-Demand' siRNA Delivery from Responsive Polymer Nanoparticles
通过响应性聚合物纳米颗粒的“按需”siRNA 传递抑制放射治疗引起的侵袭性乳腺癌转移
  • 批准号:
    9754479
  • 财政年份:
    2019
  • 资助金额:
    $ 4.48万
  • 项目类别:
Histone targeted non-viral gene delivery to enhance bone repair
组蛋白靶向非病毒基因传递以增强骨修复
  • 批准号:
    9229553
  • 财政年份:
    2014
  • 资助金额:
    $ 4.48万
  • 项目类别:
Histone targeted non-viral gene delivery to enhance bone repair
组蛋白靶向非病毒基因传递以增强骨修复
  • 批准号:
    8842129
  • 财政年份:
    2014
  • 资助金额:
    $ 4.48万
  • 项目类别:
Histone targeted non-viral gene delivery to enhance bone repair
组蛋白靶向非病毒基因传递以增强骨修复
  • 批准号:
    8613949
  • 财政年份:
    2014
  • 资助金额:
    $ 4.48万
  • 项目类别:
Histone targeted non-viral gene delivery to enhance bone repair
组蛋白靶向非病毒基因传递以增强骨修复
  • 批准号:
    9025475
  • 财政年份:
    2014
  • 资助金额:
    $ 4.48万
  • 项目类别:
SYNTHESIS & ASSEMBLY OF BIO-RESPONSIVE COPOLYMER VESICLES FOR PAYLOAD TRANSPORT
合成
  • 批准号:
    8360584
  • 财政年份:
    2011
  • 资助金额:
    $ 4.48万
  • 项目类别:
SYNTHESIS & ASSEMBLY OF BIO-RESPONSIVE COPOLYMER VESICLES FOR PAYLOAD TRANSPORT
合成
  • 批准号:
    8168490
  • 财政年份:
    2010
  • 资助金额:
    $ 4.48万
  • 项目类别:

相似海外基金

A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease
治疗阿尔茨海默病的人源化单克隆 FSH 阻断抗体
  • 批准号:
    10279706
  • 财政年份:
    2021
  • 资助金额:
    $ 4.48万
  • 项目类别:
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease
治疗阿尔茨海默病的人源化单克隆 FSH 阻断抗体
  • 批准号:
    10693288
  • 财政年份:
    2021
  • 资助金额:
    $ 4.48万
  • 项目类别:
Study of suppressing effect by PAD4 catalytic cleft blocking antibody to rheumatoid arthritis and interstitial pneumonitis
PAD4催化裂隙阻断抗体对类风湿性关节炎和间质性肺炎抑制作用的研究
  • 批准号:
    17K09982
  • 财政年份:
    2017
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Infection-blocking antibody targets for malaria
疟疾感染阻断抗体靶点
  • 批准号:
    9247922
  • 财政年份:
    2016
  • 资助金额:
    $ 4.48万
  • 项目类别:
Infection-blocking antibody targets for malaria
疟疾感染阻断抗体靶点
  • 批准号:
    9890993
  • 财政年份:
    2016
  • 资助金额:
    $ 4.48万
  • 项目类别:
Characterization of a GPCR-blocking antibody for the treatment of breast cancer.
用于治疗乳腺癌的 GPCR 阻断抗体的表征。
  • 批准号:
    8199615
  • 财政年份:
    2011
  • 资助金额:
    $ 4.48万
  • 项目类别:
Regulation of the IL-31 function by the blocking antibody to IL-31 receptor
IL-31 受体阻断抗体对 IL-31 功能的调节
  • 批准号:
    22591230
  • 财政年份:
    2010
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Animal Testing of a Blocking Antibody of PcrV
PcrV 阻断抗体的动物试验
  • 批准号:
    6444270
  • 财政年份:
    2002
  • 资助金额:
    $ 4.48万
  • 项目类别:
The detection of blocking antibody against plasma thrombopoietin in subjects with childhood idiopathic thrombocytopenic purpura
儿童特发性血小板减少性紫癜患者血浆血小板生成素阻断抗体的检测
  • 批准号:
    13670842
  • 财政年份:
    2001
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了